NovoLog approved for longer use and storage in insulin pump - MPR
Links shared publicly online about this topic.
- 1,895total visits
NovoLog approved for longer use and storage in insulin pump - MPR
empr.com —
The FDA approved a labeling change to NovoLog (insulin aspart [rDNA origin] injection, from Novo Nordisk) that allows patients with diabetes to use NovoLog in their insulin pump for up to six days.
View full resource at empr.com
Tags: Diabetes, Insulin, FDA, Novo Nordisk
Most Recently Shared on July 15, 2009 at 8:15 pm By:
MPR News: NovoLog approved for longer use and storage in insulin pump: The FDA approved a labeling chan.. http://bit.ly/aHm2P
Advertisement
